This book discusses clinical and molecular diagnosis, translational cancer treatments, and the path from there to treatment. Additionally, genetic changes, microRNAs, and long non-coding RNAs translate precision medicine for cancer patients’ individualized treatment. It explains how different pharmacogenetic factors affect how drugs’ pharmacodynamic/pharmacokinetic (PD/PK) modulations work. In fact, the current book has also considered the significance of bioinformatics and biostatistics in light of the large data analysis supporting precision medicine techniques. Therefore, the intended book presents the strong medical evidence in favor of using precision medicine to treat cancer and its potential practical applications in the future. Its current information and well-designed chapters address the gaps in cancer biology and precision medicine.
It will be an invaluable tool for interdisciplinary researchers, medical students, and scientific students. The ability to learn about cancer drug targets, precision, and personalized medicine in one place—including an introduction to cancer cell signaling, genomic alterations, miRNA targeting, pharmacogenetics, biomarkers, and metabolomics in precision medicine—is a very welcome addition for the scientific community, research institutions, and university-industry research partners.
